BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 33307338)

  • 1. Is ketamine an appropriate alternative to ECT for patients with treatment resistant depression? A systematic review.
    Veraart JKE; Smith-Apeldoorn SY; Spaans HP; Kamphuis J; Schoevers RA
    J Affect Disord; 2021 Feb; 281():82-89. PubMed ID: 33307338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol.
    Mathew SJ; Wilkinson ST; Altinay M; Asghar-Ali A; Chang LC; Collins KA; Dale RM; Hu B; Krishnan K; Kellner CH; Malone DA; Murrough JW; Ostroff RB; Sanacora G; Shao M; Anand A
    Contemp Clin Trials; 2019 Feb; 77():19-26. PubMed ID: 30572160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of the Efficacy and Adverse Effects of Ketamine and Electroconvulsive Therapy in the Management of Treatment-Resistant Depression: A Systematic Review.
    Chaudhri SI; Amin A; Panjiyar BK; Al-Taie DS; AlEdani EM; Gurramkonda J; Hamid P
    Cureus; 2024 Mar; 16(3):e55596. PubMed ID: 38576655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients.
    Basso L; Bönke L; Aust S; Gärtner M; Heuser-Collier I; Otte C; Wingenfeld K; Bajbouj M; Grimm S
    J Psychiatr Res; 2020 Apr; 123():1-8. PubMed ID: 31981856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis.
    de A Simoes Moreira D; Gauer LE; Teixeira G; Fonseca da Silva AC; Cavalcanti S; Quevedo J
    J Affect Disord; 2023 Jun; 330():227-238. PubMed ID: 36907464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic.
    Diamond PR; Farmery AD; Atkinson S; Haldar J; Williams N; Cowen PJ; Geddes JR; McShane R
    J Psychopharmacol; 2014 Jun; 28(6):536-44. PubMed ID: 24699062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression.
    Zhong X; He H; Zhang C; Wang Z; Jiang M; Li Q; Zhang M; Huang X
    J Affect Disord; 2016 Sep; 201():124-30. PubMed ID: 27208499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electroconvulsive therapy in treatment resistant depression: What is new?].
    Kaliora SC
    Psychiatriki; 2021 Dec; 32(Supplement I):82-89. PubMed ID: 34990383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
    Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
    J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial.
    Altinay M; Karne H; Anand A
    Psychopharmacol Bull; 2019 Feb; 49(1):8-16. PubMed ID: 30858635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT).
    Ekstrand J; Fattah C; Persson M; Cheng T; Nordanskog P; Åkeson J; Tingström A; Lindström MB; Nordenskjöld A; Movahed Rad P
    Int J Neuropsychopharmacol; 2022 May; 25(5):339-349. PubMed ID: 35020871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.
    Anand A; Mathew SJ; Sanacora G; Murrough JW; Goes FS; Altinay M; Aloysi AS; Asghar-Ali AA; Barnett BS; Chang LC; Collins KA; Costi S; Iqbal S; Jha MK; Krishnan K; Malone DA; Nikayin S; Nissen SE; Ostroff RB; Reti IM; Wilkinson ST; Wolski K; Hu B
    N Engl J Med; 2023 Jun; 388(25):2315-2325. PubMed ID: 37224232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine and electroconvulsive therapy: so happy together?
    Cobb K; Nanda M
    Curr Opin Anaesthesiol; 2018 Aug; 31(4):459-462. PubMed ID: 29794567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysis.
    Rhee TG; Shim SR; Forester BP; Nierenberg AA; McIntyre RS; Papakostas GI; Krystal JH; Sanacora G; Wilkinson ST
    JAMA Psychiatry; 2022 Dec; 79(12):1162-1172. PubMed ID: 36260324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and Safety of Ketamine for Unipolar Depression: a Systematic Review.
    Memon RI; Naveed S; Faquih AE; Fida A; Abbas N; Chaudhary AMD; Qayyum Z
    Psychiatr Q; 2020 Dec; 91(4):1147-1192. PubMed ID: 32852658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and tolerability of different anesthetics in electroconvulsive therapy for major depressive disorder: A systematic review and network meta-analysis.
    Ren L; Yu J; Zeng J; Wei K; Li P; Luo J; Shen Y; Lv F; Min S
    J Psychiatr Res; 2024 Mar; 171():116-125. PubMed ID: 38271762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depression.
    Tamman A; Anand A; Mathew SJ
    Expert Opin Drug Saf; 2022 Jun; 21(6):745-759. PubMed ID: 35253555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Ketamine Anesthesia on Efficacy, Tolerability, Seizure Response, and Neurocognitive Outcomes in Electroconvulsive Therapy: A Comprehensive Meta-analysis of Double-Blind Randomized Controlled Trials.
    Ainsworth NJ; Sepehry AA; Vila-Rodriguez F
    J ECT; 2020 Jun; 36(2):94-105. PubMed ID: 31725054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of ketamine in electroconvulsive therapy.
    Kucia K; Merk W
    Psychiatr Pol; 2015; 49(6):1255-63. PubMed ID: 26909400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.